Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study
- DOI
- 10.3390/cancers18111722
- Published
- 2026-05-25
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18111722,
title = {Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study},
author = {Branko Dujovic and Aleksandar Popovic and Amina Jalovcic Suljevic and Bojana Cikota-Aleksic and Mirjana Balic and Igor Salatic and Jovana Pavlica and Philipp Schnecko and Tanja Mesti and Muamer Terzo and Emina Bicakcic Filipovic and Lidija Kandolf},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18111722},
url = {https://doi.org/10.3390/cancers18111722}
}RIS
TY - JOUR TI - Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study AU - Branko Dujovic AU - Aleksandar Popovic AU - Amina Jalovcic Suljevic AU - Bojana Cikota-Aleksic AU - Mirjana Balic AU - Igor Salatic AU - Jovana Pavlica AU - Philipp Schnecko AU - Tanja Mesti AU - Muamer Terzo AU - Emina Bicakcic Filipovic AU - Lidija Kandolf PY - 2026 JO - Cancers DO - 10.3390/cancers18111722 UR - https://doi.org/10.3390/cancers18111722 ER -
APA
Dujovic, B., Popovic, A., Suljevic, A. J., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Filipovic, E. B., & Kandolf, L. (2026). Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study. Cancers. https://doi.org/10.3390/cancers18111722
Source records
- crossref · retrieved 2026-09-27T10:26:54.898Z